PET/CT en cáncer pulmonar

Metabolic imaging studies are an integral part of oncology practice, particularly with 18 fuorodeoxyglucose PET scanning. Lung cancer is one of the primary indications of a PET/CT study. It is helpful in staging, evaluating treatment response and follow-up of these patients. The recent development o...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	LADRÓN DE GUEVARA H,DAVID, PEFAUR D,RAÚL
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2010
Materias:	Lung neoplasms Positron-emission tomography Tomography scanners x-Ray computed
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872010001200015
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872010001200015
record_format	dspace
spelling	oai:scielo:S0034-988720100012000152011-01-27PET/CT en cáncer pulmonarLADRÓN DE GUEVARA H,DAVIDPEFAUR D,RAÚL Lung neoplasms Positron-emission tomography Tomography scanners x-Ray computed Metabolic imaging studies are an integral part of oncology practice, particularly with 18 fuorodeoxyglucose PET scanning. Lung cancer is one of the primary indications of a PET/CT study. It is helpful in staging, evaluating treatment response and follow-up of these patients. The recent development of PET/CT, which incorporates a multislice CT scanner to the PET detector, improves results, combining metabolic information from the PET with anatomic data obtained with CT. It reduces false positive results from PET in cases of inflammatory disease such as pneumonia or Drug reactions, which are frequent in this group of patients. These conditions are easily recognized by CT. It also improves the detection of primary tumors, when they are adjacent to atelectasis or desmoplastic reactions. PET-CT studies are able to characterize the metabolism of mediastinal and hilar lymph nodes, thus obviating the need for further related imaging studies or invasive procedures. In the assessment of metastatic disease, it allows a whole body analysis in only one study, with high predictive value and optimal cost-benefit relation. The detection of a second primary tumor is not infrequent in these patients. PET-CT is useful in the evaluation of treatment response after chemotherapy, and for the long term follow-up.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.138 n.11 20102010-11-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872010001200015es10.4067/S0034-98872010001200015
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Lung neoplasms Positron-emission tomography Tomography scanners x-Ray computed
spellingShingle	Lung neoplasms Positron-emission tomography Tomography scanners x-Ray computed LADRÓN DE GUEVARA H,DAVID PEFAUR D,RAÚL PET/CT en cáncer pulmonar
description	Metabolic imaging studies are an integral part of oncology practice, particularly with 18 fuorodeoxyglucose PET scanning. Lung cancer is one of the primary indications of a PET/CT study. It is helpful in staging, evaluating treatment response and follow-up of these patients. The recent development of PET/CT, which incorporates a multislice CT scanner to the PET detector, improves results, combining metabolic information from the PET with anatomic data obtained with CT. It reduces false positive results from PET in cases of inflammatory disease such as pneumonia or Drug reactions, which are frequent in this group of patients. These conditions are easily recognized by CT. It also improves the detection of primary tumors, when they are adjacent to atelectasis or desmoplastic reactions. PET-CT studies are able to characterize the metabolism of mediastinal and hilar lymph nodes, thus obviating the need for further related imaging studies or invasive procedures. In the assessment of metastatic disease, it allows a whole body analysis in only one study, with high predictive value and optimal cost-benefit relation. The detection of a second primary tumor is not infrequent in these patients. PET-CT is useful in the evaluation of treatment response after chemotherapy, and for the long term follow-up.
author	LADRÓN DE GUEVARA H,DAVID PEFAUR D,RAÚL
author_facet	LADRÓN DE GUEVARA H,DAVID PEFAUR D,RAÚL
author_sort	LADRÓN DE GUEVARA H,DAVID
title	PET/CT en cáncer pulmonar
title_short	PET/CT en cáncer pulmonar
title_full	PET/CT en cáncer pulmonar
title_fullStr	PET/CT en cáncer pulmonar
title_full_unstemmed	PET/CT en cáncer pulmonar
title_sort	pet/ct en cáncer pulmonar
publisher	Sociedad Médica de Santiago
publishDate	2010
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872010001200015
work_keys_str_mv	AT ladrondeguevarahdavid petctencancerpulmonar AT pefaurdraul petctencancerpulmonar
_version_	1718436538594885632

PET/CT en cáncer pulmonar

Ejemplares similares